Product Description
Mechanisms of Action: Unknown
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: N/A
FDA Designation: None *
Approval Status: Not Approved
Approved Countries: France | Hong Kong | Ireland | Morocco | Saudi Arabia | South Africa | Taiwan | Tunisia
Approved Indications: None
Known Adverse Events: None
Company: University of California, San Diego
Company Location:
Company CEO:
Additonal Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Highest Development Phases
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
---|---|---|---|---|---|
AVOCET | N/A |
Completed |
Body Weight Changes|Colorectal Cancer|Gingivitis|Obesity|Mouth Cancer|Insulin Resistance|Skin Cancer |
2015-10-01 |